biote Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BTMD research report →
Companybiote.com
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements.
- CEO
- Bret Christensen
- IPO
- 2021
- Employees
- 217
- HQ
- Irving, TX, US
Price Chart
Valuation
- Market Cap
- $92.63M
- P/E
- 4.12
- P/S
- 0.49
- P/B
- -1.15
- EV/EBITDA
- 5.36
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 69.70%
- Op Margin
- 16.14%
- Net Margin
- 8.29%
- ROE
- -22.91%
- ROIC
- 35.25%
Growth & Income
- Revenue
- $192.22M · -2.52%
- Net Income
- $27.05M · 756.67%
- EPS
- $0.86 · 833.77%
- Op Income
- $39.12M
- FCF YoY
- -22.25%
Performance & Tape
- 52W High
- $4.75
- 52W Low
- $1.27
- 50D MA
- $1.83
- 200D MA
- $2.49
- Beta
- 1.71
- Avg Volume
- 263.27K
Get TickerSpark's AI analysis on BTMD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 12, 26 | HEYER ANDREW R | other | 130,000 |
| May 12, 26 | HEYER ANDREW R | other | 35,259 |
| May 12, 26 | MORRIS DEBRA L | other | 130,000 |
| May 12, 26 | MORRIS DEBRA L | other | 21,407 |
| May 12, 26 | MORRIS DEBRA L | other | 39,036 |
| May 12, 26 | MORRIS DEBRA L | other | 21,407 |
| May 12, 26 | Cone Stephen Mark | other | 130,000 |
| May 12, 26 | Cone Stephen Mark | other | 31,481 |
| May 12, 26 | Jacoby Dana Lynn | other | 130,000 |
| May 12, 26 | Jacoby Dana Lynn | other | 37,777 |
Our BTMD Coverage
We haven't published any research on BTMD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BTMD Report →